Tarsus Pharmaceuticals In... (TARS)

TARS trades at $65.17, 44.8% above the near-term max pain of $45 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($22.5-$55), signaling increased put positioning or downside protection. Key magnetic zone at 45 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for TARS shows a downward trend from 55 to 22.5, indicating bearish sentiment or hedging activity. The 75% spread signals divergent expectations across timeframes. Most levels below 65.17 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.